Lifecore Biomedical appoints BDO USA as independent auditor for FY 2024

LIFECORE BIOMEDICAL, INC. DE

Audit committee approved BDO USA as independent auditor effective April 29, 2024 for fiscal year ending May 26, 2024.
No prior consultations with BDO on accounting principles or audit opinions were conducted.
No disagreements or reportable events with predecessor auditor were reported.

item 4.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

LIFECORE BIOMEDICAL, INC. DE engaged BDO USA, P.C. as its auditor.

Action: engagement
Auditor: BDO USA, P.C.

Exact text from the filing

On April 29, 2024, the Audit Committee of the Board of Directors of Lifecore Biomedical, Inc. (the “Company”) approved the engagement of BDO USA, P.C. (“BDO”) as the Company’s independent registered public accounting firm, effective immediately, to perform audit services for the fiscal year ending May 26, 2024.

View on SEC.gov

47 auditor changes filed in the last 30 days. Browse all auditor changes →

LIFECORE BIOMEDICAL, INC. DE filing history →

Source: SEC EDGAR

accession 0001005286-24-000054

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.